BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25533971)

  • 1. Possible association of the BRCA2 gene C5972T variant with gastric cancer: a study on Polish population.
    Ławniczak M; Jakubowska A; Białek A; Karpińska-Kaczmarczyk K; Lubiński J; Starzyńska T
    Pol Arch Med Wewn; 2015; 125(1-2):39-45. PubMed ID: 25533971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common missense variant in BRCA2 predisposes to early onset breast cancer.
    Górski B; Narod SA; Lubinski J
    Breast Cancer Res; 2005; 7(6):R1023-7. PubMed ID: 16280055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BARD1 Cys557Ser variant and breast cancer risk in Iceland.
    Stacey SN; Sulem P; Johannsson OT; Helgason A; Gudmundsson J; Kostic JP; Kristjansson K; Jonsdottir T; Sigurdsson H; Hrafnkelsson J; Johannsson J; Sveinsson T; Myrdal G; Grimsson HN; Bergthorsson JT; Amundadottir LT; Gulcher JR; Thorsteinsdottir U; Kong A; Stefansson K
    PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer.
    Kashfi SM; Behboudi Farahbakhsh F; Nazemalhosseini Mojarad E; Mashayekhi K; Azimzadeh P; Romani S; Derakhshani S; Malekpour H; Asadzadeh Aghdaei H; Zali MR
    Tumour Biol; 2016 Feb; 37(2):2119-26. PubMed ID: 26346169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population.
    Ławniczak M; Jakubowska A; Białek A; Lubiński J; Jaworska-Bieniek K; Kaczmarek K; Starzyńska T
    Hered Cancer Clin Pract; 2016; 14():3. PubMed ID: 26779294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
    Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
    J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.
    Krupa R; Sliwinski T; Morawiec Z; Pawlowska E; Zadrozny M; Blasiak J
    Exp Oncol; 2009 Dec; 31(4):250-1. PubMed ID: 20010525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant Association of Interleukin4 Intron 3 VNTR Polymorphism with Susceptibility to Gastric Cancer in a South Indian Population from Telangana.
    Bhayal AC; Krishnaveni D; Rao KP; Kumar AR; Jyothy A; Nallari P; Venkateshwari A
    PLoS One; 2015; 10(9):e0138442. PubMed ID: 26383107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy.
    Palli D; Falchetti M; Masala G; Lupi R; Sera F; Saieva C; D'Amico C; Ceroti M; Rizzolo P; Caligo MA; Zanna I; Ottini L
    BMC Cancer; 2007 Sep; 7():170. PubMed ID: 17767707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in ADH1B and ALDH2 genes associated with the increased risk of gastric cancer in West Bengal, India.
    Ghosh S; Bankura B; Ghosh S; Saha ML; Pattanayak AK; Ghatak S; Guha M; Nachimuthu SK; Panda CK; Maji S; Chakraborty S; Maity B; Das M
    BMC Cancer; 2017 Nov; 17(1):782. PubMed ID: 29166882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study.
    Couch FJ; Sinilnikova O; Vierkant RA; Pankratz VS; Fredericksen ZS; Stoppa-Lyonnet D; Coupier I; Hughes D; Hardouin A; Berthet P; Peock S; Cook M; Baynes C; Hodgson S; Morrison PJ; Porteous ME; Jakubowska A; Lubinski J; Gronwald J; Spurdle AB; ; Schmutzler R; Versmold B; Engel C; Meindl A; Sutter C; Horst J; Schaefer D; Offit K; Kirchhoff T; Andrulis IL; Ilyushik E; Glendon G; Devilee P; Vreeswijk MP; Vasen HF; Borg A; Backenhorn K; Struewing JP; Greene MH; Neuhausen SL; Rebbeck TR; Nathanson K; Domchek S; Wagner T; Garber JE; Szabo C; Zikan M; Foretova L; Olson JE; Sellers TA; Lindor N; Nevanlinna H; Tommiska J; Aittomaki K; Hamann U; Rashid MU; Torres D; Simard J; Durocher F; Guenard F; Lynch HT; Isaacs C; Weitzel J; Olopade OI; Narod S; Daly MB; Godwin AK; Tomlinson G; Easton DF; Chenevix-Trench G; Antoniou AC;
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1416-21. PubMed ID: 17627006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype.
    García-González MA; Quintero E; Bujanda L; Nicolás D; Benito R; Strunk M; Santolaria S; Sopeña F; Badía M; Hijona E; Pérez-Aísa MA; Méndez-Sánchez IM; Thomson C; Carrera P; Piazuelo E; Jiménez P; Espinel J; Campo R; Manzano M; Geijo F; Pellisé M; González-Huix F; Espinós J; Titó L; Zaballa M; Pazo R; Lanas A
    Mutagenesis; 2012 Nov; 27(6):771-7. PubMed ID: 22952149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
    Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
    Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives.
    Runnebaum IB; Wang-Gohrke S; Vesprini D; Kreienberg R; Lynch H; Moslehi R; Ghadirian P; Weber B; Godwin AK; Risch H; Garber J; Lerman C; Olopade OI; Foulkes WD; Karlan B; Warner E; Rosen B; Rebbeck T; Tonin P; Dubé MP; Kieback DG; Narod SA
    Pharmacogenetics; 2001 Oct; 11(7):635-8. PubMed ID: 11668223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study.
    Sun Y; Gu J; Ajani JA; Chang DW; Wu X; Stroehlein JR
    Cancer; 2014 Oct; 120(19):3040-8. PubMed ID: 24962126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer.
    Pérez-Pérez GI; Bosques-Padilla FJ; Crosatti ML; Tijerina-Menchaca R; Garza-González E
    Scand J Gastroenterol; 2005 Jan; 40(1):56-60. PubMed ID: 15841715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of insulin like growth facror-1 genetic polymorphism with gastric cancer susceptibility and clinicopathological features.
    Farahani RK; Azimzadeh P; Rostami E; Malekpour H; Aghdae HA; Pourhoseingholi MA; Nazemalhosseini Mojarad E; Zali MR
    Asian Pac J Cancer Prev; 2015; 16(10):4215-8. PubMed ID: 26028075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of thymidylate synthase in the 5'- and 3'-untranslated regions associated with risk of gastric cancer in South China: a case-control analysis.
    Zhang Z; Xu Y; Zhou J; Wang X; Wang L; Hu X; Guo J; Wei Q; Shen H
    Carcinogenesis; 2005 Oct; 26(10):1764-9. PubMed ID: 15930032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 and -8 gene polymorphisms and risk of gastric cancer in a population in Southwestern China.
    Pan XF; Wen Y; Loh M; Wen YY; Yang SJ; Zhao ZM; Tian Z; Huang H; Lan H; Chen F; Soong R; Yang CX
    Asian Pac J Cancer Prev; 2014; 15(7):2951-7. PubMed ID: 24815430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.